|
|
Article: Grant Life Sciences in-licenses HPV DNA-based test from Alphagenics.
- Article from:
- Business Wire
- Article date:
- November 13, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"This agreement now makes us exclusive licensee of the Alphagenics HPV DNA-based test in China, a country in which there is a very high incidence, unfortunately, of cervical cancer."
Hun-Chi Lin, Ph.D., President and Chief Scientist, Grant Life Sciences
LOS ANGELES -- Grant Life Sciences Inc. (OTC Bulletin Board: GLIF) announced today that it has signed a final agreement with Alphagenics Diaco Biotechnologies S.r.l. (Italy) to exclusively in-license the manufacturing and marketing rights to Alphagenics' molecular diagnostic test for human papillomaviruses (HPVs) in China and the United States and non-exclusively in all other countries.
The ...